These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11791079)

  • 1. Is progestogen supplementation of ERT really necessary?
    Naftolin F; Silver D
    Menopause; 2002; 9(1):1-2. PubMed ID: 11791079
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving continuation rates for hormone replacement therapy.
    Gambrell RD
    Menopause; 2002; 9(1):3-5. PubMed ID: 11791080
    [No Abstract]   [Full Text] [Related]  

  • 3. Progestogens in postmenopausal hormone therapy and the risk of breast cancer.
    Lambrinoudaki I
    Maturitas; 2014 Apr; 77(4):311-7. PubMed ID: 24485796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of the Americal Society for Reproductive Medicine
    Fertil Steril; 2004 Jan; 81(1):231-41. PubMed ID: 14711583
    [No Abstract]   [Full Text] [Related]  

  • 5. Estrogen and estrogen-progestogen replacement: therapy and cardiovascular diseases.
    Barrett-Connor E
    Am J Med; 1993 Nov; 95(5A):40S-43S. PubMed ID: 8256794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the problems of the progestogen.
    Sturdee DW; MacLennan AH
    Climacteric; 2006 Aug; 9(4):241-3. PubMed ID: 16857653
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategies to reduce the incidence of endometrial cancer in postmenopausal women.
    Gambrell RD
    Am J Obstet Gynecol; 1997 Nov; 177(5):1196-204; discussion 1204-7. PubMed ID: 9396919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
    Pike MC; Ross RK
    Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspects of hormone replacement therapy.
    Holinka CF
    Ann N Y Acad Sci; 1994 Sep; 734():271-84. PubMed ID: 7978928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of progestins].
    Wyss HI
    Arch Gynecol Obstet; 1989; 246 Suppl():S85-91. PubMed ID: 2686564
    [No Abstract]   [Full Text] [Related]  

  • 12. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
    Sturdee DW
    Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women.
    Archer DF
    Menopause; 2001; 8(4):245-51. PubMed ID: 11449081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing safety and efficacy focus on endometrial protection.
    Boroditsky RS
    J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
    Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
    Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are progestins really necessary as part of a combined HRT regimen?
    Sturdee DW
    Climacteric; 2013 Aug; 16 Suppl 1():79-84. PubMed ID: 23651281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone replacement therapy and endometrial cancer].
    Concin H; Sommerlechner M
    Gynakol Geburtshilfliche Rundsch; 1998; 38(2):93-5. PubMed ID: 9815525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical aspects of hormone replacement therapy.
    Thorneycroft IH
    Prog Cardiovasc Dis; 1995; 38(3):243-54. PubMed ID: 7494885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of endometrial cancer following estrogen replacement with and without progestins.
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
    J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Menopausal hormonal therapy and cancer risks].
    Lasserre A; Fournier A
    Gynecol Obstet Fertil; 2016; 44(7-8):424-7. PubMed ID: 27451070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.